Impaired Angiogenesis and Tumor Development by Inhibition of the Mitotic Kinesin Eg5

Overview

Journal Oncotarget

Specialty Oncology

Date 2013 Dec 12

PMID 24327603

Citations 35

Authors

Prisca Exertier

Sophie Javerzat

Baigang Wang

Melanie Franco

John Herbert

Natalia Platonova

Marie Winandy

Nadege Pujol

Olivier Nivelles

Sandra Ormenese

Virginie Godard

Jurgen Becker

Roy Bicknell

Raphael Pineau

Jorg Wilting

Andreas Bikfalvi

Martin Hagedorn

Affiliations

Soon will be listed here.

Abstract

Kinesin motor proteins exert essential cellular functions in all eukaryotes. They control mitosis, migration and intracellular transport through interaction with microtubules. Small molecule inhibitors of the mitotic kinesin KiF11/Eg5 are a promising new class of anti-neoplastic agents currently evaluated in clinical cancer trials for solid tumors and hematological malignancies. Here we report induction of Eg5 and four other mitotic kinesins including KIF20A/Mklp2 upon stimulation of in vivo angiogenesis with vascular endothelial growth factor-A (VEGF-A). Expression analyses indicate up-regulation of several kinesin-encoding genes predominantly in lymphoblasts and endothelial cells. Chemical blockade of Eg5 inhibits endothelial cell proliferation and migration in vitro. Mitosis-independent vascular outgrowth in aortic ring cultures is strongly impaired after Eg5 or Mklp2 protein inhibition. In vivo, interfering with KIF11/Eg5 function causes developmental and vascular defects in zebrafish and chick embryos and potent inhibition of tumor angiogenesis in experimental tumor models. Besides blocking tumor cell proliferation, impairing endothelial function is a novel mechanism of action of kinesin inhibitors.

Citing Articles

Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression.

Saadh M, Ghnim Z, Mahdi M, Chandra M, Ballal S, Bareja L J Mol Neurosci. 2025; 75(1):10.

PMID: 39847238 DOI: 10.1007/s12031-025-02308-9.

Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer: A Plausible Alliance to Enhance Cell Death.

Calheiros-Lobo M, Silva J, Delgado L, Pinto B, Monteiro L, Lopes C Cancers (Basel). 2024; 16(22).

PMID: 39594688 PMC: 11591835. DOI: 10.3390/cancers16223732.

Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions.

Ricci A, Carradori S, Cataldi A, Zara S Biochem Res Int. 2024; 2024:3649912.

PMID: 38939361 PMC: 11211015. DOI: 10.1155/2024/3649912.

Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell Killing.

Silva J, Pinto B, Monteiro L, Silva P, Bousbaa H Cancers (Basel). 2024; 16(11).

PMID: 38893134 PMC: 11171144. DOI: 10.3390/cancers16112014.

Phenotype-Based Genetic Analysis Reveals Missing Heritability of -Related Retinopathy: Clinical and Genetic Findings.

Chang H, Zhang X, Xu K, Li N, Xie Y, Yan W Genes (Basel). 2023; 14(1).

PMID: 36672954 PMC: 9858922. DOI: 10.3390/genes14010212.

References

Hill E, Clarke M, Barr F . The Rab6-binding kinesin, Rab6-KIFL, is required for cytokinesis. EMBO J. 2000; 19(21):5711-9. PMC: 305783. DOI: 10.1093/emboj/19.21.5711. View

Chauviere M, Kress C, Kress M . Disruption of the mitotic kinesin Eg5 gene (Knsl1) results in early embryonic lethality. Biochem Biophys Res Commun. 2008; 372(4):513-9. DOI: 10.1016/j.bbrc.2008.04.177. View

Zhang C, Zhu C, Chen H, Li L, Guo L, Jiang W . Kif18A is involved in human breast carcinogenesis. Carcinogenesis. 2010; 31(9):1676-84. DOI: 10.1093/carcin/bgq134. View

Rossler J, Taylor M, Geoerger B, Farace F, Lagodny J, Peschka-Suss R . Angiogenesis as a target in neuroblastoma. Eur J Cancer. 2008; 44(12):1645-56. DOI: 10.1016/j.ejca.2008.05.015. View

Javerzat S, Franco M, Herbert J, Platonova N, Peille A, Pantesco V . Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system. PLoS One. 2009; 4(11):e7856. PMC: 2774277. DOI: 10.1371/journal.pone.0007856. View

Baker M, Robinson S, Lechertier T, Barber P, Tavora B, DAmico G . Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc. 2011; 7(1):89-104. DOI: 10.1038/nprot.2011.435. View

Weisshardt P, Trarbach T, Durig J, Paul A, Reis H, Tilki D . Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab. Histochem Cell Biol. 2011; 137(3):391-401. DOI: 10.1007/s00418-011-0898-8. View

Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M . Inositol-requiring enzyme 1alpha is a key regulator of angiogenesis and invasion in malignant glioma. Proc Natl Acad Sci U S A. 2010; 107(35):15553-8. PMC: 2932600. DOI: 10.1073/pnas.0914072107. View

Wick N, Saharinen P, Saharinen J, Gurnhofer E, Steiner C, Raab I . Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics. 2007; 28(2):179-92. DOI: 10.1152/physiolgenomics.00037.2006. View

10.

Holen K, Belani C, Wilding G, Ramalingam S, Volkman J, Ramanathan R . A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose. Cancer Chemother Pharmacol. 2010; 67(2):447-54. PMC: 4160065. DOI: 10.1007/s00280-010-1346-5. View

11.

Amatschek S, Kriehuber E, Bauer W, Reininger B, Meraner P, Wolpl A . Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood. 2007; 109(11):4777-85. DOI: 10.1182/blood-2006-10-053280. View

12.

Takahashi S, Fusaki N, Ohta S, Iwahori Y, Iizuka Y, Inagawa K . Downregulation of KIF23 suppresses glioma proliferation. J Neurooncol. 2011; 106(3):519-29. DOI: 10.1007/s11060-011-0706-2. View

13.

Tcherniuk S, Skoufias D, Labriere C, Rath O, Gueritte F, Guillou C . Relocation of Aurora B and survivin from centromeres to the central spindle impaired by a kinesin-specific MKLP-2 inhibitor. Angew Chem Int Ed Engl. 2010; 49(44):8228-31. DOI: 10.1002/anie.201003254. View

14.

Gasnereau I, Boissan M, Margall-Ducos G, Couchy G, Wendum D, Bourgain-Guglielmetti F . KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis. Am J Pathol. 2011; 180(1):131-40. DOI: 10.1016/j.ajpath.2011.09.040. View

15.

Falnikar A, Tole S, Baas P . Kinesin-5, a mitotic microtubule-associated motor protein, modulates neuronal migration. Mol Biol Cell. 2011; 22(9):1561-74. PMC: 3084678. DOI: 10.1091/mbc.E10-11-0905. View

16.

Zhang Q, Bindokas V, Shen J, Fan H, Hoffman R, Rosie Xing H . Time-course imaging of therapeutic functional tumor vascular normalization by antiangiogenic agents. Mol Cancer Ther. 2011; 10(7):1173-84. DOI: 10.1158/1535-7163.MCT-11-0008. View

17.

Sarli V, Giannis A . Inhibitors of mitotic kinesins: next-generation antimitotics. ChemMedChem. 2006; 1(3):293-8. DOI: 10.1002/cmdc.200500045. View

18.

Chen A, Zon L . Zebrafish blood stem cells. J Cell Biochem. 2009; 108(1):35-42. DOI: 10.1002/jcb.22251. View

19.

Sugahara K, Teesalu T, Karmali P, Kotamraju V, Agemy L, Greenwald D . Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010; 328(5981):1031-5. PMC: 2881692. DOI: 10.1126/science.1183057. View

20.

Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z . Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13(1):9-22. View